DOSSIER · 13F Holders · Q1 2026
CHINA SXT PHARMACEUTICALS IN
4 institutions still hold CHINA SXT PHARMACEUTICALS IN as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP G2161P165·4 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
4 institutions reported CHINA SXT PHARMACEUTICALS IN in Q1 2026. SABBY MANAGEMENT, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.